Skip to main content
. Author manuscript; available in PMC: 2014 Mar 3.
Published in final edited form as: Psychoneuroendocrinology. 2011 Feb 12;36(7):1053–1061. doi: 10.1016/j.psyneuen.2011.01.003

Table 1.

Characteristics of Rotterdam Study participants and Whitehall II Study participants with cortisol data.

Rotterdam Study Whitehall II Study
(n=1711) (n=2836)
Gender (male) 45.4% 77.7%
Age (yrs.) 74.9(5.7) b 60.9 (5.9) b
Education
-university/polytechnic 12.0% 37.1%
Smoking 12.5% 7.7%
Diabetes Mellitus Type II 5.4% 6.6%
Coronary Heart Disease 13.2% 4.5%
Hypnotics 14.1% 1.2%
Antidepressants/Antipsychotics 4.5% 4.0%
Cortisol (nmol/L)
-at awakening 13.17(0.01-42.97) 14.80(0.10-40.05)
-30min. after awakening 16.80(0.06-51.12) 21.82(0.01-54.52)
-8h. after awakening 3.42(0.01-19.09 5.13(0.00-19.50)
-at bedtime 1.64(0.02-13.42) 1.50(0.00-13.59)
CortisolAUC (nmol/L) 8.14(3.47) b 6.93(2.29) b

Numbers are median (100% range) unless otherwise indicated

a

t test and Mann Whitney test for continuous variables and Chi-square tests for dichotomous variables.

b

mean (standard deviation)